Artificial Intelligence in Breast Cancer Screening Programs

NACompletedINTERVENTIONAL
Enrollment

31,301

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
Breast CancerScreening
Interventions
DIAGNOSTIC_TEST

Mammograms

"In the women participating in the study, two strategies for reading mammograms will be carried out:~Strategy 1: Standard reading of the program. Double independent and non-consensual reading of all cases, without any artificial intelligence system (standard strategy).~Strategy 2: Reading strategy based on the global Score granted by Transpara® (strategy based on artificial intelligence):~* In studies with a Score \<8 (studies with a low probability of cancer): They will not be evaluated by any radiologist.~* In studies with a Score\> 7 (studies with a high probability of cancer): double reading will be carried out, assisted by Transpara®."

Trial Locations (1)

14004

Hospital Universitario Reina Sofia, Córdoba

All Listed Sponsors
lead

Maimónides Biomedical Research Institute of Córdoba

OTHER